Oral Naltrexone for Alcohol Abuse Treatment
The recommended treatment protocol for oral naltrexone in alcohol abuse treatment is a standard maintenance dose of 50 mg once daily, with an initial dose of 25 mg for the first 1-3 days to assess tolerability. 1, 2
Dosing Protocol
Initial dosing:
Alternative dosing schedules (for supervised administration):
- 50 mg every weekday with 100 mg on Saturday
- 100 mg every other day
- 150 mg every third day
- Note: Higher risk of hepatocellular injury with single doses above 50 mg 2
Patient Selection
Before initiating naltrexone treatment:
Ensure patient is opioid-free:
Ideal candidates:
- Motivated patients
- Those with stable social support
- Employed individuals
- Married patients 1
Mechanism and Efficacy
Naltrexone is an opioid receptor antagonist 3 that decreases the likelihood of relapse when combined with counseling 1. It works primarily by:
- Reducing alcohol craving
- Decreasing the rewarding effects of alcohol consumption
The efficacy of naltrexone has been demonstrated in multiple clinical trials, with one study showing a 25% decrease in heavy drinking days compared to placebo 4.
Comprehensive Treatment Approach
Naltrexone should be part of a comprehensive treatment program that includes:
Behavioral therapies:
Psychosocial support:
- Group therapies
- Individual therapy
- Family/couples counseling
- Mutual aid societies (such as Alcoholics Anonymous) 3
Monitoring Treatment Response
- Assess treatment response at 12 weeks 1
- If no significant reduction in drinking is observed, consider discontinuing treatment 1
- Regular monitoring of liver function tests at baseline and every 3-6 months 1
Side Effects and Safety Considerations
Common side effects include:
- Nausea and vomiting
- Headache
- Dizziness
- Arthralgia 1
Important safety considerations:
- Hepatotoxicity concerns exist, as naltrexone undergoes hepatic metabolism 3
- Not extensively studied in patients with alcoholic liver disease 3
- Contraindicated in patients currently taking opioid medications 2
Alternative Formulations
An injectable extended-release formulation (380 mg monthly) is available as an alternative to daily oral dosing 1, 4. This formulation may improve adherence in patients who have difficulty with daily medication regimens.
Clinical Pearls
- Compliance with medication is crucial for treatment success 2
- Treatment should be considered as only one of many factors determining success in alcohol abuse treatment 2
- Implement compliance-enhancing techniques for all components of the treatment program 2
- For patients switching from buprenorphine or methadone, be prepared to manage withdrawal symptoms for up to 2 weeks 2